UBS Group’s HOOKIPA Pharma HOOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79 | Sell |
63
-30,991
| -100% | -$38.9K | ﹤0.01% | 8693 |
|
|
2025
Q1 | $33.5K | Buy |
31,054
+22,193
| +250% | +$24K | ﹤0.01% | 6573 |
|
|
2024
Q4 | $17.8K | Buy |
8,861
+5,868
| +196% | +$11.8K | ﹤0.01% | 6722 |
|
|
2024
Q3 | $12.9K | Buy |
2,993
+2,987
| +49,783% | +$12.8K | ﹤0.01% | 6400 |
|
|
2024
Q2 | $38 | Sell |
6
-1,235
| -100% | -$7.82K | ﹤0.01% | 8091 |
|
|
2024
Q1 | $8.84K | Buy |
1,241
+657
| +113% | +$4.68K | ﹤0.01% | 6139 |
|
|
2023
Q4 | $4.73K | Buy |
584
+578
| +9,633% | +$4.68K | ﹤0.01% | 6620 |
|
|
2023
Q3 | $39 | Hold |
6
| – | – | ﹤0.01% | 7896 |
|
|
2023
Q2 | $56 | Hold |
6
| – | – | ﹤0.01% | 7505 |
|
|
2023
Q1 | $47 | Sell |
6
-57
| -90% | -$446 | ﹤0.01% | 8246 |
|
|
2022
Q4 | $509 | Buy |
63
+57
| +950% | +$461 | ﹤0.01% | 8956 |
|
|
2022
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 9405 |
|
|
2022
Q2 | $0 | Sell |
6
-159
| -96% | – | ﹤0.01% | 9447 |
|
|
2022
Q1 | $4K | Sell |
165
-818
| -83% | -$19.8K | ﹤0.01% | 8238 |
|
|
2021
Q4 | $23K | Buy |
983
+675
| +219% | +$15.8K | ﹤0.01% | 6564 |
|
|
2021
Q3 | $18K | Sell |
308
-122
| -28% | -$7.13K | ﹤0.01% | 6142 |
|
|
2021
Q2 | $39K | Buy |
430
+39
| +10% | +$3.54K | ﹤0.01% | 5585 |
|
|
2021
Q1 | $53K | Buy |
391
+190
| +95% | +$25.8K | ﹤0.01% | 5479 |
|
|
2020
Q4 | $22K | Buy |
201
+177
| +738% | +$19.4K | ﹤0.01% | 5860 |
|
|
2020
Q3 | $2K | Sell |
24
-398
| -94% | -$33.2K | ﹤0.01% | 6774 |
|
|
2020
Q2 | $49K | Sell |
422
-503
| -54% | -$58.4K | ﹤0.01% | 5037 |
|
|
2020
Q1 | $76K | Sell |
925
-478
| -34% | -$39.3K | ﹤0.01% | 4646 |
|
|
2019
Q4 | $172K | Buy |
1,403
+1,032
| +278% | +$127K | ﹤0.01% | 4688 |
|
|
2019
Q3 | $28K | Buy |
371
+174
| +88% | +$13.1K | ﹤0.01% | 5569 |
|
|
2019
Q2 | $13K | Buy |
+197
| New | +$13K | ﹤0.01% | 6014 |
|